US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 1.6400
  • +0.1400+9.33%
Close May 8 16:00 ET
  • 1.6590
  • +0.0190+1.16%
Post 19:28 ET
301.14MMarket Cap-1131P/E (TTM)

Nektar Therapeutics Key Stats

Nektar Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 9, 2024

Revenue(YoY)

15.34M

-28.95%
EPS(YoY)

-0.20

+73.06%

Hold

Mar 10, 2024

Nektar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 15.342M--
May 9, 20242024/Q1-- / 15.342M--
Mar 4, 20242023/Q423.885M / 21.368M--
Nov 7, 20232023/Q324.144M / 21.313M--
Aug 8, 20232023/Q220.499M / 21.827M--
May 9, 20232023/Q121.594M / 19.426M--
--2022/Q422.023M / 22.215M--
Nov 3, 20222022/Q323.625M / 22.609M--
Aug 4, 20222022/Q221.585M / 22.745M--
--2022/Q124.822M / 24.886M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 15.342M--
May 9, 20242024/Q1-- / 15.342M--
Mar 4, 20242023/Q423.885M / 21.368M--
Nov 7, 20232023/Q324.144M / 21.313M--
Aug 8, 20232023/Q220.499M / 21.827M--
May 9, 20232023/Q121.594M / 19.426M--
--2022/Q422.023M / 22.215M--
Nov 3, 20222022/Q323.625M / 22.609M--
Aug 4, 20222022/Q221.585M / 22.745M--
--2022/Q124.822M / 24.886M--

Unlock Free Earnings Estimates

Nektar Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 10, 2024

Hold

  • Buy

    0.00%
  • Hold

    100.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg